345 related articles for article (PubMed ID: 23569206)
1. Cdc37 (cell division cycle 37) restricts Hsp90 (heat shock protein 90) motility by interaction with N-terminal and middle domain binding sites.
Eckl JM; Rutz DA; Haslbeck V; Zierer BK; Reinstein J; Richter K
J Biol Chem; 2013 May; 288(22):16032-42. PubMed ID: 23569206
[TBL] [Abstract][Full Text] [Related]
2. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors.
Gaiser AM; Kretzschmar A; Richter K
J Biol Chem; 2010 Dec; 285(52):40921-32. PubMed ID: 20880838
[TBL] [Abstract][Full Text] [Related]
3. Hsp90·Cdc37 Complexes with Protein Kinases Form Cooperatively with Multiple Distinct Interaction Sites.
Eckl JM; Scherr MJ; Freiburger L; Daake MA; Sattler M; Richter K
J Biol Chem; 2015 Dec; 290(52):30843-54. PubMed ID: 26511315
[TBL] [Abstract][Full Text] [Related]
4. Characterization of celastrol to inhibit hsp90 and cdc37 interaction.
Zhang T; Li Y; Yu Y; Zou P; Jiang Y; Sun D
J Biol Chem; 2009 Dec; 284(51):35381-9. PubMed ID: 19858214
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and structural studies of the interaction of Cdc37 with Hsp90.
Zhang W; Hirshberg M; McLaughlin SH; Lazar GA; Grossmann JG; Nielsen PR; Sobott F; Robinson CV; Jackson SE; Laue ED
J Mol Biol; 2004 Jul; 340(4):891-907. PubMed ID: 15223329
[TBL] [Abstract][Full Text] [Related]
6. A primate specific extra domain in the molecular chaperone Hsp90.
Tripathi V; Obermann WM
PLoS One; 2013; 8(8):e71856. PubMed ID: 23951259
[TBL] [Abstract][Full Text] [Related]
7. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle.
Siligardi G; Hu B; Panaretou B; Piper PW; Pearl LH; Prodromou C
J Biol Chem; 2004 Dec; 279(50):51989-98. PubMed ID: 15466438
[TBL] [Abstract][Full Text] [Related]
8. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
[TBL] [Abstract][Full Text] [Related]
9. The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy.
Sreeramulu S; Jonker HR; Langer T; Richter C; Lancaster CR; Schwalbe H
J Biol Chem; 2009 Feb; 284(6):3885-96. PubMed ID: 19073599
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones.
Prodromou C; Siligardi G; O'Brien R; Woolfson DN; Regan L; Panaretou B; Ladbury JE; Piper PW; Pearl LH
EMBO J; 1999 Feb; 18(3):754-62. PubMed ID: 9927435
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Hsp90 ATPase activity by the co-chaperone Cdc37p/p50cdc37.
Siligardi G; Panaretou B; Meyer P; Singh S; Woolfson DN; Piper PW; Pearl LH; Prodromou C
J Biol Chem; 2002 Jun; 277(23):20151-9. PubMed ID: 11916974
[TBL] [Abstract][Full Text] [Related]
12. Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity.
Mollapour M; Tsutsumi S; Truman AW; Xu W; Vaughan CK; Beebe K; Konstantinova A; Vourganti S; Panaretou B; Piper PW; Trepel JB; Prodromou C; Pearl LH; Neckers L
Mol Cell; 2011 Mar; 41(6):672-81. PubMed ID: 21419342
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide-Free sB-Raf is Preferentially Bound by Hsp90 and Cdc37 In Vitro.
Eckl JM; Daake M; Schwartz S; Richter K
J Mol Biol; 2016 Oct; 428(20):4185-4196. PubMed ID: 27620500
[TBL] [Abstract][Full Text] [Related]
14. Dual inhibition of chaperoning process by taxifolin: molecular dynamics simulation study.
Verma S; Singh A; Mishra A
J Mol Graph Model; 2012 Jul; 37():27-38. PubMed ID: 22609743
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric activation of the hsp90 dimer by its cochaperone aha1.
Retzlaff M; Hagn F; Mitschke L; Hessling M; Gugel F; Kessler H; Richter K; Buchner J
Mol Cell; 2010 Feb; 37(3):344-54. PubMed ID: 20159554
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery.
Meyer P; Prodromou C; Liao C; Hu B; Roe SM; Vaughan CK; Vlasic I; Panaretou B; Piper PW; Pearl LH
EMBO J; 2004 Mar; 23(6):1402-10. PubMed ID: 15039704
[TBL] [Abstract][Full Text] [Related]
17. Hsp90/Cdc37 chaperone/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A.
Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
BMC Bioinformatics; 2011 Feb; 12 Suppl 1(Suppl 1):S30. PubMed ID: 21342561
[TBL] [Abstract][Full Text] [Related]
18. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
19. Domain-mediated dimerization of the Hsp90 cochaperones Harc and Cdc37.
Roiniotis J; Masendycz P; Ho S; Scholz GM
Biochemistry; 2005 May; 44(17):6662-9. PubMed ID: 15850399
[TBL] [Abstract][Full Text] [Related]
20. The conserved NxNNWHW motif in Aha-type co-chaperones modulates the kinetics of Hsp90 ATPase stimulation.
Mercier R; Wolmarans A; Schubert J; Neuweiler H; Johnson JL; LaPointe P
Nat Commun; 2019 Mar; 10(1):1273. PubMed ID: 30894538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
